Use of the Antral Follicle Count to Predict the Outcome of Assisted Reproductive Technologies Ming-Yang Chang, Chi-Hsin Chiang, T’sang-T’ang Hsieh, Yung-Kuei.

Slides:

Advertisements

Similar presentations

Role of Anti-Mullerian hormone in prediction of Assisted Reproductive Technology outcomes Leili Safdarian M.D. Khadigeh Khosravi M.D. Marzieh Agha Hosseini.

Advertisements

Carlos Morán, M. D. , Eric Knochenhauer, M. D. , Larry R Boots, Ph. D

Ovarian pregnancy following intrauterine insemination

Krinos M. Trokoudes, M. D. , Constantinos Pavlides, M. Sc

A giant oocyte in a cohort of retrieved oocytes: does it have any effect on the in vitro fertilization cycle outcome? Ronit Machtinger, M.D., Joseph.

Longitudinal depressive symptoms and state anxiety among women using assisted reproductive technology Anjel Vahratian, Ph.D., M.P.H., Yolanda R. Smith,

Low-dosage clomiphene reduces premature ovulation rates and increases transfer rates in natural-cycle IVF M von Wolff, M Nitzschke, P Stute, N Bitterlich,

Yan Tang, M. D. , M. Sc. , Shi-Ling Chen, M. D. , Ph. D. , Xin Chen, M

Evaluation of basal estradiol levels in assisted reproductive technology cycles2 John L Frattarelli, M.D., Paul A Bergh, M.D., Michael R Drews, M.D.,

Antral follicle count (AFC) can be used in the prediction of ovarian response but cannot predict the oocyte/embryo quality or the in vitro fertilization.

Mike Ripley, M. D. , F. R. C. S. C. , Andrea Lanes, M. Sc

Patient-tailored ovarian stimulation for in vitro fertilization

In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation

Zhi-Yong Yang, M.D., Ri-Cheng Chian, Ph.D. Fertility and Sterility

A randomized comparative study of the effects of oral and topical estrogen therapy on the lower urinary tract of hysterectomized postmenopausal women

Society of Thoracic Surgeons Score Predicts Kidney Injury in Patients Not Undergoing Bypass Surgery Chih-Hsiang Chang, MD, Chung-Ming Fu, MD, Chia-Hung.

Ethnicity as a determinant of ovarian reserve: differences in ovarian aging between Spanish and Indian women Carlos Iglesias, M.D., Manish Banker, M.D.,

Antimüllerian hormone levels and antral follicle count as prognostic indicators in a personalized prediction model of live birth Scott M. Nelson, M.R.C.O.G.,

Antimüllerian hormone levels and antral follicle counts are not reduced compared with community controls in patients with rigorously defined unexplained.

The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count Simone L. Broer, B.Sc., Ben Willem J.

Biomarkers of ovarian response: current and future applications

Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm.

Insurance mandates and trends in infertility treatments

Reproductive aging and variability in the ovarian antral follicle count: application in the clinical setting Karl R Hansen, M.D., Ph.D., Jamie L Morris,

Improved monofollicular ovulation in anovulatory or oligo-ovulatory women after a low- dose step-up protocol with weekly increments of 25 international.

Oocyte cryopreservation

Evaluating the performance of serum antimullerian hormone concentration in predicting the live birth rate of controlled ovarian stimulation and intrauterine.

Assisted reproductive technology in the United States: 1999 results generated from the American Society for reproductive medicine/society for assisted.

Chao-Chin Hsu, M. D. , Ph. D. , Hsin-Chih Kuo, Ph. D

Effects of acupuncture on pregnancy rates in women undergoing in vitro fertilization: a systematic review and meta-analysis Cui Hong Zheng, M.D., Ph.D.,

Albert Hsu, M. D. , Margaret Arny, Ph. D. , Alexander B. Knee, M. S

Calculating cumulative live-birth rates from linked cycles of assisted reproductive technology (ART): data from the Massachusetts SART CORS Judy E. Stern,

Microdose flare protocol with interrupted follicle stimulating hormone and added androgen for poor responders—an observational pilot study Frederic Mitri,

Clinical Assessment of Recombinant Human Follicle-Stimulating Hormone in Stimulating Ovarian Follicular Development Before In Vitro Fertilization fn1

Benny Almog, M. D. , Fady Shehata, M. B. , B. Ch. , M. Sc

David E. Reichman, M.D., Dan Goldschlag, M.D., Zev Rosenwaks, M.D.

Impact of pituitary suppression on antral follicle count and oocyte recovery after ovarian stimulation Nam D. Tran, M.D., Ph.D., Lusine Aghajanova, M.D.,

Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis.

Insulin-like growth factor-II (IGF-II), IGF-binding protein-3 (IGFBP-3), and IGFBP-4 in follicular fluid are associated with oocyte maturation and embryo.

Nondominant small follicles are a promising source of mature oocytes in modified natural cycle in vitro fertilization and embryo transfer Shokichi Teramoto,

Effectiveness of ultrasound-guided aspiration and sclerotherapy with 95% ethanol for treatment of recurrent ovarian endometriomas Chia-Lin Hsieh, M.D.,

Immature oocyte retrieval and in vitro oocyte maturation at different phases of the menstrual cycle in women with cancer who require urgent gonadotoxic.

Granulosa–lutein cell growth differentiation factor-9 (GDF-9) messenger RNA and protein expression in in vitro fertilization (IVF) cycles: relation to.

Birth outcomes after spontaneous or assisted conception among infertile Australian women aged 28 to 36 years: a prospective, population-based study Danielle.

Tania Luisa Stevenson, M.B.Ch.B., Hany Lashen, F.R.C.O.G.

Prospective cohort study of three- versus two-dimensional ultrasound for prediction of oocyte maturity Doron Shmorgun, M.D., Edward Hughes, M.D., Patrick.

Predictive usefulness of cycle day 10 follicle-stimulating hormone level in a clomiphene citrate challenge test for in vitro fertilization outcome in.

A double-blind clinical trial comparing a fixed daily dose of 150 and 250 IU of recombinant follicle-stimulating hormone in women undergoing in vitro.

Regulation of assisted reproductive technologies in the United States

Derivation of developmentally competent oocytes by in vitro culture of preantral follicles retrieved from aged mice Jung Kyu Choi, B.Sc., Jong Il Ahn,

Detection of the subendometrial vascularization flow index by three-dimensional ultrasound may be useful for predicting the pregnancy rate for patients.

Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis.

L. Scott, J. Bernsten, K. DeLegge, J. Hill, N. Ramsing

The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is.

Antral follicle counts are strongly associated with live-birth rates after assisted reproduction, with superior treatment outcome in women with polycystic.

Yen-Ni Teng, Ph. D. , Yung-Ming Lin, M. D. , Hsiao-Fang Sunny Sun, Ph

Eric S. Surrey, M. D. , Debra A. Minjarez, M. D. , John M. Stevens, B

Percutaneous oocyte retrieval from an inguinal ovary

Tsan-Hon Liou, M. D. , Ph. D. , Jen-Hung Yang, M. D. , Ph. D

David H. Barad, M.D., M.S., Norbert Gleicher, M.D.

Serum anti-Mullerian hormone dynamics during stimulated cycles by aromatase inhibitor anastrozole and clomiphene citrate in women with infertility H.-H.

Effectiveness of human menopausal gonadotropin versus recombinant follicle- stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive.

Krinos M. Trokoudes, M. D. , Constantinos Pavlides, M. Sc

Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles David.

Which patients pursue fertility preservation treatments

Performance of basal follicle-stimulating hormone and patient's age in the prediction of poor ovarian response and IVF outcome of women who developed.

Conversion from assisted reproductive technology to intrauterine insemination in low responders: Is it advantageous? John M. Norian, M.D., Eric D. Levens,

Basal antral follicle number and mean ovarian diameter predict cycle cancellation and ovarian responsiveness in assisted reproductive technology cycles2

A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three- dimensional ultrasound determinants of ovarian reserve in the prediction.

Day-5 inhibin B serum concentrations and antral follicle count as predictors of ovarian response and live birth in assisted reproduction cycles stimulated.

Presentation transcript:

Use of the Antral Follicle Count to Predict the Outcome of Assisted Reproductive Technologies Ming-Yang Chang, Chi-Hsin Chiang, T’sang-T’ang Hsieh, Yung-Kuei Soong, Kuang-Hung Hsu Fertility and Sterility Volume 69, Issue 3, Pages 505-510 (March 1998) DOI: 10.1016/S0015-0282(97)00557-8

Fig. 1 Scattergram with 95% confidence bands for correlation analysis of number of oocytes retrieved and antral follicle count detected at the beginning of treatment cycles in women who underwent ARTs (no. of oocytes = −0.154 + 0.881 × antral follicle 2–5 mm, R2 = 0.556). Fertility and Sterility 1998 69, 505-510DOI: (10.1016/S0015-0282(97)00557-8)